Two S&P 500 funds hold nearly identical stocks, yet their returns have drifted so far apart over a decade that the gap itself tells a story about what most investors misunderstand about diversification.
Paradigm's revelation that it holds Zcash sent shockwaves through the crypto market, but the timeline raises a provocative question about who really drove this rally and whether new buyers are walking into a trap.
Patent cliffs have buried lesser pharma dividends, yet these four Big Pharma giants keep raising payouts despite losing blockbuster exclusivities worth billions. Find out which one has held its streak for 64 straight years…
A dividend can be slashed the moment a board votes to cut it, but not every guaranteed alternative actually guarantees what investors assume. Before you choose income over certainty or certainty over income, the…
Nvidia just posted triple-digit revenue growth and Jensen Huang says the company can only fulfill 70% of demand, yet the stock still trades well below where the math points. Three converging forces suggest the…
New York recognizes a legal mechanism that lets a well spouse refuse to pay for nursing home care without losing Medicaid coverage for the sick one, but the letter you sign in the morning…
Warren Buffett built Berkshire Hathaway into a dividend-collecting machine even though the company refuses to pay one itself, and five of his biggest holdings are quietly handing shareholders more cash every single year.
A defense analyst warned that China may be watching gleefully as the Pentagon scrambles to restock two weapons classes critical to any future great-power fight. Four defense contractors sit at the center of a…
AMD just crossed a trillion-dollar market cap and the sell side is scrambling to rewrite its models in real time, but the gap between the bulls racing to raise targets and the bears warning…
CRISPR Therapeutics owns the only approved gene therapy of its kind, yet the stock sits far below where Wall Street thinks it belongs. One analyst sees a path to gains that would embarrass the…
Bitcoin surged nearly 17% in under a week, but the rally had almost nothing to do with steady buying pressure. Two explosive sessions tell the real story, and the forces behind them reveal whether…
Most people pick an Arizona city the way they pick a state, assuming the differences are minor until a July afternoon or a specialist waitlist corrects them. The retirees who moved twice share a…
AT&T, Verizon, and Pfizer all trade under $50 a share, but a low entry price and genuine value are two very different things, and only one of these three high-yield names carries a coverage…
Uber still holds a 13.5% stake in Grab, a board seat just got surrendered, and billions are now pointed at a completely different continent. The signals buried in a securities filing tell a story…
SpaceX shares have punched through $150 twice now, fueled by billion-dollar defense contracts and a constellation no rival can match, but the balance sheet tells a story Wall Street may not be ready to…
